GeneDx (WGS) Competitors $114.22 -7.25 (-5.97%) Closing price 09/24/2025 04:00 PM EasternExtended Trading$114.30 +0.08 (+0.07%) As of 04:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock WGS vs. HIMS, GH, RDNT, BTSG, SHC, OPCH, SGRY, CON, PRVA, and VCYTShould you be buying GeneDx stock or one of its competitors? The main competitors of GeneDx include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. GeneDx vs. Its Competitors Hims & Hers Health Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health Surgery Partners Concentra Group Holdings Parent Privia Health Group Veracyte GeneDx (NASDAQ:WGS) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability. Which has more volatility and risk, WGS or HIMS? GeneDx has a beta of 2.04, suggesting that its stock price is 104% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500. Does the media refer more to WGS or HIMS? In the previous week, Hims & Hers Health had 21 more articles in the media than GeneDx. MarketBeat recorded 36 mentions for Hims & Hers Health and 15 mentions for GeneDx. GeneDx's average media sentiment score of 0.54 beat Hims & Hers Health's score of 0.46 indicating that GeneDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GeneDx 7 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 18 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer WGS or HIMS? GeneDx currently has a consensus price target of $104.13, suggesting a potential downside of 8.84%. Hims & Hers Health has a consensus price target of $38.92, suggesting a potential downside of 27.00%. Given GeneDx's stronger consensus rating and higher possible upside, equities analysts plainly believe GeneDx is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeneDx 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Is WGS or HIMS more profitable? Hims & Hers Health has a net margin of 9.63% compared to GeneDx's net margin of 0.39%. Hims & Hers Health's return on equity of 26.26% beat GeneDx's return on equity.Company Net Margins Return on Equity Return on Assets GeneDx0.39% 16.51% 9.35% Hims & Hers Health 9.63%26.26%13.06% Which has stronger valuation and earnings, WGS or HIMS? Hims & Hers Health has higher revenue and earnings than GeneDx. Hims & Hers Health is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeneDx$305.45M10.74-$52.29M$0.052,284.40Hims & Hers Health$1.48B8.16$126.04M$0.8066.64 Do insiders and institutionals believe in WGS or HIMS? 61.7% of GeneDx shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 29.6% of GeneDx shares are held by company insiders. Comparatively, 13.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryHims & Hers Health beats GeneDx on 9 of the 16 factors compared between the two stocks. Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WGS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WGS vs. The Competition Export to ExcelMetricGeneDxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.49B$7.71B$5.77B$10.42BDividend YieldN/A2.77%5.68%4.61%P/E Ratio2,284.4072.9276.2826.42Price / Sales10.7438.71552.28127.65Price / Cash118.7122.2537.5661.52Price / Book13.056.8513.186.39Net Income-$52.29M$245.04M$3.29B$271.13M7 Day Performance-12.62%-0.06%0.84%0.93%1 Month Performance-6.28%3.50%5.03%7.52%1 Year Performance210.04%12.32%71.27%30.06% GeneDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WGSGeneDx2.3645 of 5 stars$114.22-6.0%$104.13-8.8%+192.3%$3.49B$305.45M2,284.401,200HIMSHims & Hers Health2.6547 of 5 stars$50.32-1.1%$38.92-22.7%+208.7%$11.50B$1.48B62.901,637Insider TradeGHGuardant Health3.798 of 5 stars$57.19+3.2%$58.24+1.8%+155.6%$6.91B$739.02M-17.072,021Analyst ForecastGap UpRDNTRadNet3.1701 of 5 stars$75.20+1.1%$76.80+2.1%+8.2%$5.72B$1.91B-375.9811,021BTSGBrightSpring Health Services1.7626 of 5 stars$27.40+1.1%$27.10-1.1%+78.9%$4.80B$11.27B88.3935,000SHCSotera Health2.3962 of 5 stars$16.25-0.3%$16.00-1.5%-6.8%$4.63B$1.10B203.153,000OPCHOption Care Health4.8616 of 5 stars$28.03+1.7%$35.75+27.5%-12.6%$4.47B$5.00B22.428,088Positive NewsAnalyst ForecastSGRYSurgery Partners3.1105 of 5 stars$21.79+1.1%$33.00+51.4%-32.9%$2.76B$3.11B-15.2415,000CONConcentra Group Holdings Parent3.099 of 5 stars$20.81-2.8%$27.50+32.2%-10.7%$2.74B$1.90B17.4811,250PRVAPrivia Health Group4.4049 of 5 stars$22.21-0.5%$28.58+28.7%+28.7%$2.74B$1.74B201.931,140Trending NewsAnalyst ForecastAnalyst RevisionVCYTVeracyte3.8609 of 5 stars$31.83-1.4%$40.90+28.5%-3.1%$2.54B$445.76M96.46790Positive News Related Companies and Tools Related Companies HIMS Competitors GH Competitors RDNT Competitors BTSG Competitors SHC Competitors OPCH Competitors SGRY Competitors CON Competitors PRVA Competitors VCYT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WGS) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WGS Stock Alerts